Bitter gourd (Momordica charantia), also known as karela or bitter melon, is widely used in South Asian communities across the UK as a traditional remedy for managing blood sugar. But does bitter gourd decrease HbA1c in any clinically meaningful way? This article examines the bioactive compounds thought to influence glucose metabolism, reviews the current clinical evidence — including the Cochrane systematic review — and explains what UK guidelines say about herbal remedies in diabetes care. It also covers how to use bitter gourd safely alongside prescribed treatment and when to seek medical advice.

What Is Bitter Gourd and How Might It Affect Blood Sugar?

Bitter gourd contains bioactive compounds — including charantin, vicine, and momordicins — proposed to influence glucose metabolism, but these mechanisms are based primarily on laboratory and animal studies and have not been reliably confirmed in humans.

Bitter gourd (Momordica charantia), also known as bitter melon or karela, is a tropical fruit widely used in South Asian, African, and Caribbean cuisines. It has a long history of use in traditional medicine systems — including Ayurveda and traditional Chinese medicine — as a natural remedy for managing elevated blood sugar levels. In the UK, it is commonly consumed as a vegetable, juice, or dietary supplement, particularly within South Asian communities.

From a pharmacological standpoint, bitter gourd contains several bioactive compounds that are thought to influence glucose metabolism. These include:

• Charantin — a steroidal glycoside believed to have hypoglycaemic properties

• Polypeptide-p (plant insulin) — a plant-derived insulin-like peptide; however, as a peptide it is likely to be broken down during digestion and is therefore unlikely to be orally bioavailable or effective when ingested

• Vicine — a pyrimidine glycoside with potential glucose-lowering effects

• Momordicins — cucurbitane-type triterpenoids that may also contribute to metabolic activity

These compounds have been proposed to work through multiple mechanisms, including enhancing insulin secretion from pancreatic beta cells, improving peripheral glucose uptake, inhibiting intestinal glucose absorption, and activating AMP-activated protein kinase (AMPK) — a key enzyme involved in cellular energy regulation and glucose homeostasis. Some researchers have also suggested that bitter gourd may improve insulin sensitivity, which is particularly relevant in type 2 diabetes.

It is important to emphasise that these proposed mechanisms are based primarily on laboratory (in vitro) and animal studies. They have not been reliably confirmed in humans at the doses achievable through dietary consumption or standard supplement use. Understanding the distinction between preclinical mechanistic hypotheses and proven clinical benefit is essential before drawing firm conclusions about bitter gourd's role in diabetes management.

Evidence on Bitter Gourd and HbA1c Reduction

A Cochrane systematic review found insufficient evidence that bitter gourd produces clinically meaningful HbA1c reductions in type 2 diabetes; subsequent meta-analyses have similarly found results to be modest and inconsistent.

HbA1c (glycated haemoglobin) is the primary long-term marker of blood glucose control, reflecting average blood sugar levels over approximately two to three months. Reducing HbA1c is a central goal in diabetes management, as sustained reductions are associated with lower risks of complications such as retinopathy, nephropathy, and cardiovascular disease.

Several small-scale clinical trials and systematic reviews have investigated whether bitter gourd can meaningfully reduce HbA1c in people with type 2 diabetes. The results have been mixed and, overall, unconvincing.

A 2011 randomised controlled trial published in the Journal of Ethnopharmacology found that bitter gourd preparations did not significantly reduce HbA1c over a four-week period. It is worth noting that four weeks is too short a duration to robustly assess HbA1c change, given that this marker reflects glucose control over two to three months.

Importantly, a Cochrane systematic review (2012) on Momordica charantia for type 2 diabetes mellitus concluded that there was insufficient evidence to recommend bitter gourd as an effective glucose-lowering intervention. The review highlighted the poor methodological quality of available trials and the absence of clinically meaningful reductions in HbA1c compared with placebo or active comparators. More recent systematic reviews and meta-analyses (published between 2014 and 2021) have similarly found that any reductions in fasting blood glucose or HbA1c reported in individual trials were modest, inconsistent across studies, and not of a magnitude that would be considered clinically significant in routine diabetes care.

Key limitations across the existing research include:

• Small sample sizes with limited statistical power

• Short study durations that are insufficient to capture meaningful HbA1c changes

• Inconsistent preparations — studies use varying forms (juice, capsules, dried powder), making direct comparisons difficult

• Lack of standardisation in dosing and bioactive compound content

• High risk of bias in many trials

• Limited reporting of effect sizes, making clinical interpretation difficult

In summary, while there is biological plausibility for bitter gourd having some effect on blood sugar regulation, the current clinical evidence — including the Cochrane review and subsequent meta-analyses — does not robustly confirm that it produces clinically significant reductions in HbA1c. Patients should be cautious about interpreting preliminary findings as definitive proof of benefit.

What UK Clinical Guidelines Say About Herbal Remedies in Diabetes

NICE guidelines do not recommend bitter gourd or any herbal remedy for diabetes management, and no MHRA THR-registered product is indicated for controlling blood glucose or reducing HbA1c.

In the United Kingdom, diabetes management is guided primarily by the National Institute for Health and Care Excellence (NICE). NICE guidelines for type 2 diabetes (NG28) and type 1 diabetes (NG17) focus on evidence-based pharmacological treatments — including metformin, SGLT-2 inhibitors, GLP-1 receptor agonists, and insulin — alongside structured lifestyle interventions such as dietary modification, physical activity, and weight management.

NICE guidelines do not currently recommend bitter gourd or any other herbal remedy as part of standard diabetes care. This is not because such remedies are necessarily harmful, but because the evidence base does not meet the rigorous standards required for clinical recommendation.

The Medicines and Healthcare products Regulatory Agency (MHRA) regulates herbal medicines in the UK under the Traditional Herbal Registration (THR) scheme. It is important to understand what the THR mark does and does not mean: it provides assurance of product quality and safety for traditional use in minor, self-limiting conditions only. It does not demonstrate clinical efficacy, and no THR-registered product is indicated for the treatment or management of diabetes. Patients should be aware that a product carrying a THR mark should not be making medicinal claims about controlling blood glucose or reducing HbA1c.

The NHS advises patients to be cautious about using complementary or herbal remedies alongside prescribed medications, particularly for conditions like diabetes where blood glucose control is critical. Healthcare professionals are encouraged to ask patients about herbal supplement use as part of routine consultations, as many patients do not voluntarily disclose this information.

It is also worth noting that dietary patterns incorporating vegetables with a low glycaemic index — including bitter gourd consumed as a food — are broadly consistent with NHS Eatwell Guide principles. However, consuming bitter gourd as part of a balanced diet is entirely distinct from using concentrated supplements with the expectation of a therapeutic effect on HbA1c. These should not be conflated.

Safe Ways to Use Bitter Gourd Alongside Prescribed Diabetes Treatment

Bitter gourd can be included as a low-glycaemic vegetable in a balanced diet, but supplement use requires GP disclosure, frequent blood glucose monitoring, and must never replace or alter prescribed diabetes treatment.

For individuals who wish to include bitter gourd in their diet or lifestyle, there are sensible and safe approaches that do not conflict with conventional diabetes management — provided certain precautions are observed.

As a dietary food: Incorporating bitter gourd as a vegetable in cooking is generally considered safe for most people. It is low in calories, contains dietary fibre, and has a low glycaemic index, all of which are consistent with dietary recommendations for people with diabetes. Dishes such as karela sabzi (stir-fried bitter gourd) or adding it to soups and curries can be a nutritious addition to a balanced diet.

If considering supplements: Those who wish to use bitter gourd in supplement form (capsules, powders, or concentrated juices) should:

• Inform their GP or diabetes nurse before starting, particularly if they are taking glucose-lowering medications

• Be aware that THR-registered products are not indicated for diabetes and that no supplement should be used with the expectation of controlling blood glucose or replacing prescribed treatment

• Avoid products making medicinal claims about glycaemic control, as these would not be legally compliant under UK regulations

• Monitor blood glucose more frequently when first introducing any supplement, to detect unexpected changes — follow NHS guidance on self-monitoring and be familiar with the signs and treatment of hypoglycaemia

• Never self-adjust prescribed medication doses based on perceived effects of the supplement; any changes to prescribed treatment must be discussed with your clinician

It is also important to maintain all scheduled diabetes reviews, including HbA1c testing, retinal screening, and foot checks, as recommended by your GP or diabetes care team. Bitter gourd should never be viewed as a replacement for prescribed treatment. If used at all, it should be considered a complementary addition to — not a substitute for — evidence-based care. Open communication with your healthcare team is the cornerstone of safe self-management.

Risks, Interactions, and When to Speak to Your GP

The most clinically significant risk is hypoglycaemia when bitter gourd is combined with insulin or sulphonylureas; people with G6PD deficiency, liver disease, or pregnancy should avoid high-dose preparations and seek GP advice.

While bitter gourd is generally well tolerated when consumed as a food, there are important safety considerations — particularly when used in larger quantities or as a concentrated supplement.

Potential adverse effects include:

Experiencing these side effects? Our pharmacists can help you navigate them →

• Hypoglycaemia (low blood sugar): This is the most clinically significant risk, particularly in people already taking insulin, sulphonylureas (such as gliclazide), or other glucose-lowering agents. Combining these medications with bitter gourd may produce an additive glucose-lowering effect. Mild to moderate hypoglycaemia (shakiness, sweating, palpitations, hunger) can usually be self-treated with fast-acting carbohydrate. However, if someone is unconscious, fitting, or unable to swallow, this is a medical emergency — call 999 immediately.

• Gastrointestinal symptoms: Nausea, abdominal pain, and diarrhoea have been reported, especially with juice or high-dose preparations.

• Liver effects: Rare cases of elevated liver enzymes have been documented in association with bitter gourd supplements. If you develop jaundice (yellowing of the skin or whites of the eyes), dark urine, pale stools, severe abdominal pain, or persistent nausea, stop taking the supplement and seek medical advice promptly.

• Favism risk: Bitter gourd seeds contain vicine, a pyrimidine glycoside that may trigger haemolytic anaemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency — a condition more prevalent in some South Asian, African, and Mediterranean populations. People with known G6PD deficiency should avoid bitter gourd seeds and high-dose preparations.

Drug interactions: Caution is warranted when combining bitter gourd with any glucose-lowering medication, given the potential for additive hypoglycaemic effects. There is insufficient robust evidence to confirm interactions with anticoagulants or immunosuppressants, and these are not included in standard UK drug interaction databases; patients taking such medicines should discuss supplement use with their GP or pharmacist before proceeding.

Pregnancy and breastfeeding: Bitter gourd is not recommended during pregnancy. Animal studies have raised concerns about uterotonic effects, and there are insufficient human safety data to establish that it is safe for use during pregnancy or breastfeeding. If you are pregnant, planning a pregnancy, or breastfeeding, speak to your GP or midwife before using bitter gourd in any form beyond normal culinary quantities.

You should speak to your GP or diabetes care team if:

• You experience symptoms of hypoglycaemia after starting bitter gourd

• You notice unexplained changes in your blood glucose readings

• You develop any signs of liver problems (jaundice, dark urine, pale stools, severe abdominal pain)

• You are pregnant, planning a pregnancy, or breastfeeding

• You have liver disease, G6PD deficiency, or are taking multiple medications

Reporting suspected adverse reactions: If you experience a suspected side effect from a herbal supplement, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. This helps the MHRA monitor the safety of herbal products available in the UK.

Always prioritise open, honest conversations with your healthcare team about any complementary remedies you are using or considering.

Frequently Asked Questions